Administration of wild-type p53 adenoviral vector synergistically enhances the cytotoxicity of anti-cancer drugs in human lung cancer cells irrespective of the status of p53 gene
- 11 July 2000
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 157 (1) , 105-112
- https://doi.org/10.1016/s0304-3835(00)00480-8
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: